|1.||Pfeilschifter, Josef: 2 articles (12/2014 - 01/2014)|
|2.||Zangemeister-Wittke, Uwe: 2 articles (12/2014 - 01/2014)|
|3.||Schwalm, Stephanie: 2 articles (12/2014 - 01/2014)|
|4.||Pastukhov, Oleksandr: 2 articles (12/2014 - 01/2014)|
|5.||Huwiler, Andrea: 2 articles (12/2014 - 01/2014)|
|6.||Bornancin, Frederic: 1 article (12/2014)|
|7.||Fabbro, Doriano: 1 article (12/2014)|
|8.||Japtok, Lukasz: 1 article (12/2014)|
|9.||Kleuser, Burkhard: 1 article (12/2014)|
|10.||Römer, Isolde: 1 article (01/2014)|
12/01/2014 - "Here, we studied the effect of a recently developed CerK inhibitor, NVP-231, on cancer cell proliferation and viability and investigated the role of cell cycle regulators implicated in these responses. "
12/01/2014 - "Our data demonstrate for the first time a crucial role for CerK in the M phase control in cancer cells and suggest its targeted inhibition, using drugs such as NVP-231, in combination with conventional pro-apoptotic chemotherapy."
|2.||Lung Neoplasms (Lung Cancer)
12/01/2014 - "The breast and lung cancer cell lines MCF-7 and NCI-H358 were treated with increasing concentrations of NVP-231 and DNA synthesis, colony formation and cell death were determined. "
12/01/2014 - "The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death."
|1.||DNA (Deoxyribonucleic Acid)
|1.||Drug Therapy (Chemotherapy)